|
Charles Lee
Director, Molecular Genetic Research Unit
Associate Professor, Harvard Medical School
Associate Member, Broad Institute of MIT and Harvard
Clinical Cytogeneticist, Brigham and Women’s Hospital
|
| |
Biosketch:
Dr. Lee’s research unit centers on the use of molecular cytogenetic technologies to study the structure of vertebrate genomes to understand human diseases. He received his doctoral degree from the University of Alberta (Canada) in 1996, was an NSERC research fellow at the University of Cambridge (UK) from 1996-1998, a clinical cytogenetics fellow at Harvard Medical School (USA) from 1998-2001, and then became board certified by the American Board of Medical Genetics in 2002 in Clinical Cytogenetics.
Dr. Lee is currently the principal investigator on grants from the National Cancer Institute, the National Human Genome Research Institute, and the National Institute of General Medicine. He has authored / coauthored over 100 publications in top journals such as Nature, Science, Cell, Proceedings of the National Academy of Sciences USA, and Nature Genetics. He currently chairs the American Society of Human Genetics Program Committee, co-chairs the structural variation analysis group for the International 1000 Genomes Project ( www.1000genomes.org), is a regular member of the Genes, Health and Development Study Section at the National Institutes of Health, and serves as an Associate Editor for the American Journal of Human Genetics.
Among the fellowships / awards that he has received, he was the recipient of a Ph.D. studentship from the Alberta Heritage Foundation for Medical Research, postdoctoral fellowship awards from both the Medical Research Council of Canada and the Natural Sciences and Engineering Research Council of Canada, the Inaugural Team Award from the American Association for Cancer Research (2007), the C. Thomas Caskey Lectureship from the University of South Carolina (2008), and the George Brumley Jr Award from Duke University (2010). In 2008, at the age of 39, Dr. Lee became the youngest recipient of the Ho-Am Prize in Medicine (also referred to as the "Korean Nobel Prize") for his 2004 discovery of widespread structural genomic variation in the human genome and his seminal contributions to this new field of human genetics. |
